A qualitative study exploring patient and healthcare provider experiences of transfusion in myelodysplastic syndromes (MDS): Phase 2 of the REDDS2 trial

  • McQuilten, Zoe (Primary Chief Investigator (PCI))
  • Mo, Allison (Chief Investigator (CI))
  • Pritchard, Elizabeth (Chief Investigator (CI))
  • Shortt, Jake (Chief Investigator (CI))
  • Wood, Erica (Chief Investigator (CI))
  • Stanworth, Simon J. (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date5/12/19 → 31/12/26

Funding

  • National Blood Authority (NBA) (Australia): A$91,504.00